| Target Price | A$4.87 |
| Price | A$4.44 |
| Potential |
9.58%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Atlas Arteria 2027 .
The average Atlas Arteria target price is A$4.87.
This is
9.58%
register free of charge
A$5.58
25.57%
register free of charge
A$4.55
2.36%
register free of charge
|
|
| A rating was issued by 14 analysts: 1 Analysts recommend Atlas Arteria to buy, 6 to hold and 7 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Atlas Arteria stock has an average upside potential 2027 of
9.58%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million A$ | 160.00 | 158.18 |
| 9.66% | 1.14% | |
| EBITDA Margin | 30.31% | 916.05% |
| 50.47% | 2,922.02% | |
| Net Margin | 113.63% | 153.78% |
| 44.78% | 35.34% |
10 Analysts have issued a sales forecast Atlas Arteria 2026 . The average Atlas Arteria sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Atlas Arteria EBITDA forecast 2026. The average Atlas Arteria EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Atlas Arteria Analysts have issued a net profit forecast 2026. The average Atlas Arteria net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | 0.13 | 0.17 |
| 38.10% | 30.77% | |
| P/E | 26.48 | |
| EV/Sales | 49.23 |
10 Analysts have issued a Atlas Arteria forecast for earnings per share. The average Atlas Arteria EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jun 21 2026 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Apr 21 2026 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Mar 02 2026 |
| E&P |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| E&P |
Locked
➜
Locked
|
Locked | Feb 26 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Feb 26 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jun 21 2026 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Apr 21 2026 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Mar 02 2026 |
|
Locked
E&P:
Locked
➜
Locked
|
Feb 27 2026 |
|
Locked
E&P:
Locked
➜
Locked
|
Feb 26 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Feb 26 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Oct 22 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


